Retraction: Metoprolol, N-Acetylcysteine, and Escitalopram Prevents Chronic Unpredictable Mild Stress-Induced Depression by Inhibition of Endoplasmic Reticulum Stress
Clinical Scorecard: Retraction Notice: The Role of Metoprolol, N-Acetylcysteine, and Escitalopram in Mitigating Depression Induced by Chronic Unpredictable Mild Stress Through Endoplasmic Reticulum Stress Inhibition
At a Glance
Category Detail
Condition Depression Key Mechanisms Endoplasmic Reticulum Stress Inhibition Target Population Patients experiencing chronic unpredictable mild stress Care Setting Psychiatric research
Key Highlights
Retraction of the original research article due to concerns about data integrity. Authors failed to provide raw data during the investigation. Retraction approved by the Chief Editors of Frontiers in Psychiatry. Concerns raised by users on PubPeer regarding published figures. Guideline-Based Recommendations
Diagnosis
No specific guidelines available due to retraction. Management
No specific management guidelines available due to retraction. Monitoring & Follow-up
No specific monitoring guidelines available due to retraction. Risks
No specific risk guidelines available due to retraction. Patient & Prescribing Data
Not applicable due to retraction.
Not applicable due to retraction.
Clinical Best Practices
No clinical best practices available due to retraction. Related Resources & Content
